

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.86386805 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.86386805 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.86386805 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.86386805 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.86386805 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.86386805 |
| 7 | microglial cell activation (GO:0001774) | 6.80894802 |
| 8 | positive regulation of chemokine secretion (GO:0090197) | 5.99027794 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.93271277 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.78318084 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.66250620 |
| 12 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.15631114 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 5.08069677 |
| 14 | response to peptidoglycan (GO:0032494) | 4.84876676 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.78595616 |
| 16 | regulation of chemokine secretion (GO:0090196) | 4.68201450 |
| 17 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.67402358 |
| 18 | response to host immune response (GO:0052572) | 4.67402358 |
| 19 | macrophage activation (GO:0042116) | 4.45632461 |
| 20 | respiratory burst (GO:0045730) | 4.45601273 |
| 21 | cellular extravasation (GO:0045123) | 4.44411483 |
| 22 | response to host (GO:0075136) | 4.39009153 |
| 23 | response to host defenses (GO:0052200) | 4.39009153 |
| 24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.39009153 |
| 25 | hemidesmosome assembly (GO:0031581) | 4.38290584 |
| 26 | detection of other organism (GO:0098543) | 4.37631615 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 4.34522442 |
| 28 | detection of external biotic stimulus (GO:0098581) | 4.29909005 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.26503953 |
| 30 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.24369406 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11454397 |
| 32 | negative regulation of granulocyte differentiation (GO:0030853) | 4.10960839 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 4.09350758 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 4.08509690 |
| 35 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.03493705 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.99740934 |
| 37 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.94960497 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.93773703 |
| 39 | detection of bacterium (GO:0016045) | 3.83027196 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.78961505 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.75942365 |
| 42 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.73030331 |
| 43 | neutrophil activation (GO:0042119) | 3.68160625 |
| 44 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.67248844 |
| 45 | granulocyte activation (GO:0036230) | 3.65607183 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61212517 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.61212517 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.55636605 |
| 49 | I-kappaB phosphorylation (GO:0007252) | 3.53067791 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.50130520 |
| 51 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.46951573 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44899893 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.40524079 |
| 54 | negative regulation of interleukin-6 production (GO:0032715) | 3.39933249 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.38794223 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.37905959 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.35408446 |
| 58 | macrophage differentiation (GO:0030225) | 3.33829931 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.33421294 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.31789117 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.31789117 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.25788057 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 3.25120147 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24475048 |
| 65 | hypotonic response (GO:0006971) | 3.21330283 |
| 66 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.20099850 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13545278 |
| 68 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.13343172 |
| 69 | regulation of macrophage cytokine production (GO:0010935) | 3.11970354 |
| 70 | regulation of mast cell activation (GO:0033003) | 3.11474349 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.11228518 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11086530 |
| 73 | purinergic receptor signaling pathway (GO:0035587) | 3.10751724 |
| 74 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09692410 |
| 75 | neutrophil mediated immunity (GO:0002446) | 3.07942065 |
| 76 | negative regulation of interleukin-17 production (GO:0032700) | 3.07230774 |
| 77 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.07028206 |
| 78 | oligosaccharide catabolic process (GO:0009313) | 3.06166806 |
| 79 | hyaluronan catabolic process (GO:0030214) | 3.05466897 |
| 80 | glycosphingolipid catabolic process (GO:0046479) | 3.05303303 |
| 81 | neutrophil chemotaxis (GO:0030593) | 3.04807305 |
| 82 | myeloid leukocyte mediated immunity (GO:0002444) | 3.03577531 |
| 83 | superoxide anion generation (GO:0042554) | 3.02485634 |
| 84 | myeloid leukocyte activation (GO:0002274) | 3.01325017 |
| 85 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01173108 |
| 86 | keratan sulfate catabolic process (GO:0042340) | 3.00481956 |
| 87 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00398147 |
| 88 | adaptation of signaling pathway (GO:0023058) | 3.00274209 |
| 89 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98535753 |
| 90 | positive regulation of interferon-beta production (GO:0032728) | 2.97660858 |
| 91 | leukocyte degranulation (GO:0043299) | 2.96864270 |
| 92 | tolerance induction (GO:0002507) | 2.96345078 |
| 93 | leukocyte aggregation (GO:0070486) | 2.95969853 |
| 94 | neutrophil migration (GO:1990266) | 2.95429633 |
| 95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.93991748 |
| 96 | regulation of regulated secretory pathway (GO:1903305) | 2.93842039 |
| 97 | positive regulation of chemokine production (GO:0032722) | 2.92379041 |
| 98 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91213135 |
| 99 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.91080178 |
| 100 | regulation of B cell differentiation (GO:0045577) | 2.90231593 |
| 101 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.88562221 |
| 102 | regulation of leukocyte degranulation (GO:0043300) | 2.85099997 |
| 103 | T-helper 1 type immune response (GO:0042088) | 2.83784819 |
| 104 | positive regulation of regulated secretory pathway (GO:1903307) | 2.81619366 |
| 105 | reactive oxygen species biosynthetic process (GO:1903409) | 2.80381780 |
| 106 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79944673 |
| 107 | phagocytosis, engulfment (GO:0006911) | 2.78469533 |
| 108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77955187 |
| 109 | positive regulation of leukocyte degranulation (GO:0043302) | 2.77605899 |
| 110 | regulation of tolerance induction (GO:0002643) | 2.76154107 |
| 111 | cyclooxygenase pathway (GO:0019371) | 2.74803416 |
| 112 | regulation of hypersensitivity (GO:0002883) | 2.73183023 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72997577 |
| 114 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.72769579 |
| 115 | B cell mediated immunity (GO:0019724) | 2.72362160 |
| 116 | negative regulation of B cell proliferation (GO:0030889) | 2.71054993 |
| 117 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70634110 |
| 118 | negative regulation of bone resorption (GO:0045779) | 2.70384723 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69405619 |
| 120 | glycolipid catabolic process (GO:0019377) | 2.68259299 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67782314 |
| 122 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.67258908 |
| 123 | regulation of interleukin-17 production (GO:0032660) | 2.66830710 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66485373 |
| 125 | macrophage chemotaxis (GO:0048246) | 2.64856105 |
| 126 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64555464 |
| 127 | granulocyte chemotaxis (GO:0071621) | 2.62736381 |
| 128 | germinal center formation (GO:0002467) | 2.61842125 |
| 129 | pinocytosis (GO:0006907) | 2.61546909 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61335941 |
| 131 | B cell receptor signaling pathway (GO:0050853) | 2.58961367 |
| 132 | positive regulation of macrophage cytokine production (GO:0060907) | 2.58538993 |
| 133 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58412677 |
| 134 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.58209545 |
| 135 | cytokine secretion (GO:0050663) | 2.58186183 |
| 136 | protein localization to endosome (GO:0036010) | 2.58127184 |
| 137 | regulation of interleukin-6 production (GO:0032675) | 2.57345301 |
| 138 | response to cholesterol (GO:0070723) | 2.56983912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.33617392 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.91482088 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.69935746 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.38029187 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.29235233 |
| 6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49239844 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.24397737 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21612368 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.16617641 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.97270246 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.95537500 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91876024 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.80085374 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.69270790 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61220896 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.46751747 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45794126 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41957418 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28296195 |
| 20 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.16277683 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13103714 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12537933 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.12459514 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11364704 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10013103 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02629470 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97510594 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.94828854 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90741329 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74752428 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74059376 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68060679 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67820675 |
| 34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67081278 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65974007 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63835032 |
| 37 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63318642 |
| 38 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.62074701 |
| 39 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.62074701 |
| 40 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.62074701 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.59401131 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.56544720 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53107624 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52305426 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50965553 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47243966 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46053357 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44585808 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40820662 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.40173183 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38835221 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37752479 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37752479 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37739404 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37080025 |
| 56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36087066 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35579284 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.33242820 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29006817 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.26914405 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26641838 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26481256 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23795849 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12888771 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12311743 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12027992 |
| 67 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11311869 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09737307 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07604879 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06445851 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06079666 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05324670 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04628383 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04151190 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03405361 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02464906 |
| 77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00030434 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98940623 |
| 79 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98870102 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97458848 |
| 81 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96175451 |
| 82 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95926973 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94522120 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94053651 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93662083 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92142376 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91557860 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91451305 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91448415 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90698290 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90583366 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90418667 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90373883 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90254404 |
| 95 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90231856 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88947543 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88725805 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88458136 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87714620 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86931734 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86631129 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86361123 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85435847 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84968321 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.84896754 |
| 106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83919720 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83091306 |
| 108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83015051 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82528989 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79597219 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79207429 |
| 112 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77196929 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76188477 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75946199 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75905090 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75215181 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74929789 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70664314 |
| 119 | MYC_22102868_ChIP-Seq_BL_Human | 0.70236473 |
| 120 | CJUN_26792858_Chip-Seq_BT549_Human | 0.69143777 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69019073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 4.24484830 |
| 2 | MP0003303_peritoneal_inflammation | 3.89175026 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.70548110 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.68421442 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.53894771 |
| 6 | MP0003436_decreased_susceptibility_to | 3.44864887 |
| 7 | MP0002419_abnormal_innate_immunity | 3.21986107 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.97837013 |
| 9 | MP0005671_abnormal_response_to | 2.94792071 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.76935172 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.72335841 |
| 12 | MP0009785_altered_susceptibility_to | 2.70891554 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.69159479 |
| 14 | MP0005025_abnormal_response_to | 2.53821889 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.53407580 |
| 16 | MP0003724_increased_susceptibility_to | 2.53018771 |
| 17 | MP0003075_altered_response_to | 2.39495377 |
| 18 | MP0002723_abnormal_immune_serum | 2.32788947 |
| 19 | MP0001800_abnormal_humoral_immune | 2.31193536 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.23120902 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.14341295 |
| 22 | MP0001819_abnormal_immune_cell | 2.12972446 |
| 23 | MP0001790_abnormal_immune_system | 2.12132175 |
| 24 | MP0005387_immune_system_phenotype | 2.12132175 |
| 25 | MP0000343_altered_response_to | 2.09767319 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.09586106 |
| 27 | MP0009278_abnormal_bone_marrow | 2.06167306 |
| 28 | MP0000685_abnormal_immune_system | 2.04366202 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.98193641 |
| 30 | MP0001853_heart_inflammation | 1.84769461 |
| 31 | MP0003690_abnormal_glial_cell | 1.80312188 |
| 32 | MP0002405_respiratory_system_inflammati | 1.79668282 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.76028263 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.72841575 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.70603515 |
| 36 | MP0002254_reproductive_system_inflammat | 1.69788639 |
| 37 | MP0001851_eye_inflammation | 1.69476724 |
| 38 | MP0008004_abnormal_stomach_pH | 1.60632585 |
| 39 | MP0008469_abnormal_protein_level | 1.58399856 |
| 40 | MP0005409_darkened_coat_color | 1.57113271 |
| 41 | MP0004947_skin_inflammation | 1.55118060 |
| 42 | MP0005451_abnormal_body_composition | 1.50361560 |
| 43 | MP0000716_abnormal_immune_system | 1.50100936 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.48664190 |
| 45 | MP0004510_myositis | 1.45525378 |
| 46 | MP0005166_decreased_susceptibility_to | 1.44422751 |
| 47 | MP0009840_abnormal_foam_cell | 1.43624142 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.43335262 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.41923334 |
| 50 | MP0004883_abnormal_blood_vessel | 1.41763542 |
| 51 | MP0003828_pulmonary_edema | 1.39925234 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.38988296 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.38988296 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.37753451 |
| 55 | MP0005310_abnormal_salivary_gland | 1.36983662 |
| 56 | MP0001958_emphysema | 1.36887283 |
| 57 | MP0003448_altered_tumor_morphology | 1.35908383 |
| 58 | MP0002398_abnormal_bone_marrow | 1.33683378 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.33071857 |
| 60 | MP0006054_spinal_hemorrhage | 1.32802209 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.29119725 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.26718845 |
| 63 | MP0000579_abnormal_nail_morphology | 1.24459319 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.23986543 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.23302870 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.22176113 |
| 67 | MP0000858_altered_metastatic_potential | 1.20855686 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.20773728 |
| 69 | MP0009764_decreased_sensitivity_to | 1.20708964 |
| 70 | MP0002429_abnormal_blood_cell | 1.19357617 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.18536066 |
| 72 | MP0003045_fibrosis | 1.16105841 |
| 73 | MP0000920_abnormal_myelination | 1.16084863 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.16072048 |
| 75 | MP0005275_abnormal_skin_tensile | 1.14802673 |
| 76 | MP0005390_skeleton_phenotype | 1.14153925 |
| 77 | MP0002722_abnormal_immune_system | 1.12999932 |
| 78 | MP0005023_abnormal_wound_healing | 1.12653257 |
| 79 | MP0002132_abnormal_respiratory_system | 1.11714856 |
| 80 | MP0005164_abnormal_response_to | 1.11597981 |
| 81 | MP0002060_abnormal_skin_morphology | 1.06965880 |
| 82 | MP0000681_abnormal_thyroid_gland | 1.05021912 |
| 83 | MP0002933_joint_inflammation | 0.99096336 |
| 84 | MP0010678_abnormal_skin_adnexa | 0.97855795 |
| 85 | MP0000383_abnormal_hair_follicle | 0.97131269 |
| 86 | MP0002090_abnormal_vision | 0.96821892 |
| 87 | MP0002006_tumorigenesis | 0.96230565 |
| 88 | MP0000249_abnormal_blood_vessel | 0.90235902 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.85364805 |
| 90 | MP0001849_ear_inflammation | 0.85302824 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 0.84152248 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.83965974 |
| 93 | MP0008873_increased_physiological_sensi | 0.83786909 |
| 94 | MP0003011_delayed_dark_adaptation | 0.83484741 |
| 95 | MP0009763_increased_sensitivity_to | 0.82586806 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.82581530 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.82274855 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.82247820 |
| 99 | MP0002928_abnormal_bile_duct | 0.81553057 |
| 100 | MP0000371_diluted_coat_color | 0.81518442 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.80321623 |
| 102 | MP0003866_abnormal_defecation | 0.79327186 |
| 103 | MP0000604_amyloidosis | 0.77799119 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.76492963 |
| 105 | MP0005388_respiratory_system_phenotype | 0.76058638 |
| 106 | MP0002133_abnormal_respiratory_system | 0.76058638 |
| 107 | MP0004858_abnormal_nervous_system | 0.74330509 |
| 108 | MP0003795_abnormal_bone_structure | 0.73103176 |
| 109 | MP0000490_abnormal_crypts_of | 0.72163034 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.71364442 |
| 111 | MP0001915_intracranial_hemorrhage | 0.70665778 |
| 112 | MP0004381_abnormal_hair_follicle | 0.69651188 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.69204391 |
| 114 | MP0005257_abnormal_intraocular_pressure | 0.66913206 |
| 115 | MP0008260_abnormal_autophagy | 0.66886723 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.66719114 |
| 117 | MP0003091_abnormal_cell_migration | 0.66041464 |
| 118 | MP0005076_abnormal_cell_differentiation | 0.64893858 |
| 119 | MP0003279_aneurysm | 0.62862782 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.62207989 |
| 121 | MP0005165_increased_susceptibility_to | 0.61721492 |
| 122 | MP0008874_decreased_physiological_sensi | 0.57039820 |
| 123 | MP0003634_abnormal_glial_cell | 0.55723960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.14490624 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.78531497 |
| 3 | Glomerulonephritis (HP:0000099) | 6.44617099 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.31829128 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.18006699 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.91689989 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.91689989 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.91689989 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.94169297 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.89160790 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.83013970 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.22776962 |
| 13 | Complement deficiency (HP:0004431) | 4.21664176 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.94575231 |
| 15 | Recurrent skin infections (HP:0001581) | 3.89926056 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.77256083 |
| 17 | Arterial tortuosity (HP:0005116) | 3.75424113 |
| 18 | Retinal atrophy (HP:0001105) | 3.69022587 |
| 19 | Axonal loss (HP:0003447) | 3.65867518 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.64593321 |
| 21 | Myositis (HP:0100614) | 3.64187796 |
| 22 | Milia (HP:0001056) | 3.63575837 |
| 23 | Abnormality of complement system (HP:0005339) | 3.62487758 |
| 24 | Hematochezia (HP:0002573) | 3.58829473 |
| 25 | Nephritis (HP:0000123) | 3.56500062 |
| 26 | Mutism (HP:0002300) | 3.54212346 |
| 27 | Disinhibition (HP:0000734) | 3.50525821 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.38409083 |
| 29 | Obstructive lung disease (HP:0006536) | 3.30354934 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30354934 |
| 31 | Gingivitis (HP:0000230) | 3.30138346 |
| 32 | Vascular tortuosity (HP:0004948) | 3.26840470 |
| 33 | Orchitis (HP:0100796) | 3.21536322 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.18645295 |
| 35 | Recurrent fungal infections (HP:0002841) | 3.16449579 |
| 36 | Onycholysis (HP:0001806) | 3.15994376 |
| 37 | Cerebral aneurysm (HP:0004944) | 3.10043714 |
| 38 | Colitis (HP:0002583) | 3.02713560 |
| 39 | Stomatitis (HP:0010280) | 3.02433193 |
| 40 | Atrophic scars (HP:0001075) | 3.00798863 |
| 41 | Peritonitis (HP:0002586) | 2.98870065 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.88950296 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.88950296 |
| 44 | Cellulitis (HP:0100658) | 2.83916101 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.81986525 |
| 46 | Agnosia (HP:0010524) | 2.81507031 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77949219 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77949219 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77949219 |
| 50 | Amyloidosis (HP:0011034) | 2.75686616 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.74627371 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.74192764 |
| 53 | Fragile nails (HP:0001808) | 2.71745541 |
| 54 | Plantar hyperkeratosis (HP:0007556) | 2.71625236 |
| 55 | Epistaxis (HP:0000421) | 2.70058333 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.69448974 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.66369412 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.62076457 |
| 59 | Optic neuritis (HP:0100653) | 2.55957785 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.55957785 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.55448372 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53372776 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53372776 |
| 64 | Chest pain (HP:0100749) | 2.51388516 |
| 65 | Chronic diarrhea (HP:0002028) | 2.50798563 |
| 66 | Recurrent viral infections (HP:0004429) | 2.50796916 |
| 67 | Thick nail (HP:0001805) | 2.49264834 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.44942741 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40422553 |
| 70 | Hemoptysis (HP:0002105) | 2.40422110 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.39265881 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.37936678 |
| 73 | Vasculitis (HP:0002633) | 2.36645555 |
| 74 | Neuronal loss in central nervous system (HP:0002529) | 2.34972975 |
| 75 | Basal ganglia calcification (HP:0002135) | 2.34538433 |
| 76 | Progressive visual loss (HP:0000529) | 2.32181951 |
| 77 | Urticaria (HP:0001025) | 2.29538897 |
| 78 | Skin ulcer (HP:0200042) | 2.28777006 |
| 79 | Upper motor neuron abnormality (HP:0002127) | 2.27751701 |
| 80 | Meningitis (HP:0001287) | 2.26106716 |
| 81 | Disproportionate tall stature (HP:0001519) | 2.25594807 |
| 82 | Loss of speech (HP:0002371) | 2.24164942 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.21839104 |
| 84 | Aortic aneurysm (HP:0004942) | 2.21503576 |
| 85 | Pustule (HP:0200039) | 2.20834681 |
| 86 | T lymphocytopenia (HP:0005403) | 2.19316528 |
| 87 | Abnormal blistering of the skin (HP:0008066) | 2.17413388 |
| 88 | Pathologic fracture (HP:0002756) | 2.14502757 |
| 89 | Cheilitis (HP:0100825) | 2.12799207 |
| 90 | Encephalitis (HP:0002383) | 2.11753946 |
| 91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10921153 |
| 92 | Osteomyelitis (HP:0002754) | 2.10793506 |
| 93 | Urethral obstruction (HP:0000796) | 2.09804288 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.09801834 |
| 95 | Abnormality of T cell number (HP:0011839) | 2.09484569 |
| 96 | Leukocytosis (HP:0001974) | 2.09006439 |
| 97 | Petechiae (HP:0000967) | 2.07900528 |
| 98 | Recurrent pneumonia (HP:0006532) | 2.07826466 |
| 99 | Periodontitis (HP:0000704) | 2.06899042 |
| 100 | Abnormal platelet volume (HP:0011876) | 2.04505398 |
| 101 | Orthostatic hypotension (HP:0001278) | 2.04374857 |
| 102 | Episodic fever (HP:0001954) | 2.03263362 |
| 103 | Increased IgE level (HP:0003212) | 2.02363665 |
| 104 | Abnormality of nail color (HP:0100643) | 1.99356151 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 1.98124381 |
| 106 | Viral hepatitis (HP:0006562) | 1.96366624 |
| 107 | Thrombocytosis (HP:0001894) | 1.95322367 |
| 108 | Chronic otitis media (HP:0000389) | 1.94322517 |
| 109 | Subacute progressive viral hepatitis (HP:0006572) | 1.93264942 |
| 110 | Pulmonary infiltrates (HP:0002113) | 1.92916005 |
| 111 | Prostate neoplasm (HP:0100787) | 1.92497295 |
| 112 | Spondylolisthesis (HP:0003302) | 1.89603240 |
| 113 | Nail dystrophy (HP:0008404) | 1.89564547 |
| 114 | Inappropriate behavior (HP:0000719) | 1.88258770 |
| 115 | Pulmonary embolism (HP:0002204) | 1.84725725 |
| 116 | Thoracic kyphosis (HP:0002942) | 1.84279322 |
| 117 | Apathy (HP:0000741) | 1.84167100 |
| 118 | Aortic dissection (HP:0002647) | 1.83773705 |
| 119 | Peripheral demyelination (HP:0011096) | 1.83618606 |
| 120 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83020573 |
| 121 | Arterial thrombosis (HP:0004420) | 1.82125116 |
| 122 | Diminished motivation (HP:0000745) | 1.81386239 |
| 123 | Osteolytic defects of the hand bones (HP:0009699) | 1.80696112 |
| 124 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80696112 |
| 125 | Glomerulopathy (HP:0100820) | 1.80596752 |
| 126 | Bruising susceptibility (HP:0000978) | 1.79731266 |
| 127 | Myocardial infarction (HP:0001658) | 1.79652871 |
| 128 | Thickened calvaria (HP:0002684) | 1.79368487 |
| 129 | Gingival bleeding (HP:0000225) | 1.78969690 |
| 130 | Striae distensae (HP:0001065) | 1.78699480 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.78322872 |
| 132 | Abnormal platelet function (HP:0011869) | 1.78322872 |
| 133 | Alopecia of scalp (HP:0002293) | 1.77916993 |
| 134 | Palmoplantar hyperkeratosis (HP:0000972) | 1.76779125 |
| 135 | Eosinophilia (HP:0001880) | 1.76043504 |
| 136 | Granulocytopenia (HP:0001913) | 1.75637102 |
| 137 | Polycythemia (HP:0001901) | 1.75157741 |
| 138 | Pili torti (HP:0003777) | 1.73940271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 6.61800050 |
| 2 | GRK7 | 3.61833906 |
| 3 | CSF1R | 3.53649441 |
| 4 | RIPK4 | 3.45482550 |
| 5 | BLK | 3.44482748 |
| 6 | MAPK15 | 3.06237557 |
| 7 | IRAK4 | 2.80436744 |
| 8 | TYK2 | 2.60318911 |
| 9 | TBK1 | 2.21619804 |
| 10 | STK10 | 2.09848152 |
| 11 | ERN1 | 2.06366867 |
| 12 | MAP3K2 | 2.03227618 |
| 13 | MAP3K14 | 1.85611045 |
| 14 | MATK | 1.83872361 |
| 15 | CSK | 1.74524177 |
| 16 | ADRBK2 | 1.73660113 |
| 17 | IRAK3 | 1.73432036 |
| 18 | KIT | 1.72648423 |
| 19 | TAOK3 | 1.64349655 |
| 20 | EPHB1 | 1.62685023 |
| 21 | PAK4 | 1.60789788 |
| 22 | MAP4K1 | 1.58288188 |
| 23 | KSR2 | 1.57280652 |
| 24 | IKBKB | 1.57012583 |
| 25 | HCK | 1.45589351 |
| 26 | MAP2K3 | 1.43129544 |
| 27 | JAK1 | 1.41998264 |
| 28 | CLK1 | 1.40899930 |
| 29 | ZAP70 | 1.40674467 |
| 30 | ITK | 1.39908626 |
| 31 | MOS | 1.38436128 |
| 32 | PRPF4B | 1.38178332 |
| 33 | GRK5 | 1.34374425 |
| 34 | MAPKAPK3 | 1.24535915 |
| 35 | CAMK1D | 1.19123351 |
| 36 | FES | 1.18284595 |
| 37 | IKBKE | 1.17012416 |
| 38 | FGR | 1.16849466 |
| 39 | TRPM7 | 1.16661684 |
| 40 | MAP3K13 | 1.15933512 |
| 41 | MAP3K1 | 1.15234493 |
| 42 | EEF2K | 1.14637062 |
| 43 | BTK | 1.13669183 |
| 44 | LYN | 1.13591821 |
| 45 | TXK | 1.05614104 |
| 46 | MAPKAPK5 | 1.04895295 |
| 47 | TEC | 0.98707172 |
| 48 | TRIB3 | 0.96377660 |
| 49 | MAPK12 | 0.96226097 |
| 50 | JAK2 | 0.95482871 |
| 51 | RPS6KA4 | 0.95321239 |
| 52 | LCK | 0.93231525 |
| 53 | TTN | 0.90000853 |
| 54 | MARK3 | 0.88637365 |
| 55 | SYK | 0.88516606 |
| 56 | SIK2 | 0.88436716 |
| 57 | GRK1 | 0.85849428 |
| 58 | PTK2B | 0.85572992 |
| 59 | RAF1 | 0.84099904 |
| 60 | MAPK7 | 0.83232532 |
| 61 | RET | 0.82617409 |
| 62 | TSSK6 | 0.78940549 |
| 63 | CDK12 | 0.78731512 |
| 64 | PBK | 0.77621264 |
| 65 | MAP3K6 | 0.77064367 |
| 66 | CAMK1G | 0.74664856 |
| 67 | PRKD2 | 0.74437233 |
| 68 | TNK2 | 0.72649555 |
| 69 | MAP3K11 | 0.71961548 |
| 70 | CDK3 | 0.70624617 |
| 71 | RPS6KC1 | 0.69078241 |
| 72 | RPS6KL1 | 0.69078241 |
| 73 | RPS6KA2 | 0.68143798 |
| 74 | MAP3K5 | 0.67433472 |
| 75 | TAOK1 | 0.66496178 |
| 76 | LRRK2 | 0.66477251 |
| 77 | SGK3 | 0.66294700 |
| 78 | PIM2 | 0.65901899 |
| 79 | CDC42BPA | 0.63799642 |
| 80 | JAK3 | 0.63261078 |
| 81 | WNK1 | 0.63243139 |
| 82 | EIF2AK2 | 0.63174056 |
| 83 | GRK6 | 0.61651648 |
| 84 | CHUK | 0.59990947 |
| 85 | SIK1 | 0.59942271 |
| 86 | IGF1R | 0.59722943 |
| 87 | RPS6KA6 | 0.59551847 |
| 88 | YES1 | 0.58664166 |
| 89 | CAMK4 | 0.58390359 |
| 90 | PDGFRB | 0.57491345 |
| 91 | VRK1 | 0.56302397 |
| 92 | FLT3 | 0.54999558 |
| 93 | EGFR | 0.54590829 |
| 94 | IRAK2 | 0.53624005 |
| 95 | IRAK1 | 0.51788672 |
| 96 | MAP3K3 | 0.51509818 |
| 97 | FGFR3 | 0.50683814 |
| 98 | STK24 | 0.50089920 |
| 99 | MST1R | 0.47431392 |
| 100 | SGK2 | 0.46829680 |
| 101 | CAMKK2 | 0.46762800 |
| 102 | MAP3K10 | 0.45071037 |
| 103 | HIPK2 | 0.44434774 |
| 104 | KSR1 | 0.44276705 |
| 105 | MARK2 | 0.44020440 |
| 106 | NEK9 | 0.43651389 |
| 107 | PDK1 | 0.43033665 |
| 108 | ABL1 | 0.42820682 |
| 109 | FER | 0.42188308 |
| 110 | PRKG2 | 0.41713923 |
| 111 | MAP2K4 | 0.40978189 |
| 112 | PRKCD | 0.40732168 |
| 113 | ARAF | 0.40062245 |
| 114 | * MAPKAPK2 | 0.39838179 |
| 115 | PDK2 | 0.39202347 |
| 116 | LMTK2 | 0.39121829 |
| 117 | MAP3K7 | 0.39095130 |
| 118 | STK38 | 0.38972048 |
| 119 | MST4 | 0.36447329 |
| 120 | MAPK4 | 0.35849327 |
| 121 | BMPR2 | 0.35735462 |
| 122 | PRKCQ | 0.35429806 |
| 123 | GSK3A | 0.35307106 |
| 124 | SMG1 | 0.34732194 |
| 125 | RIPK1 | 0.34727662 |
| 126 | PIM1 | 0.34523146 |
| 127 | PIK3CG | 0.34382143 |
| 128 | PTK6 | 0.34319935 |
| 129 | CDK6 | 0.34140563 |
| 130 | INSR | 0.31853978 |
| 131 | ERBB3 | 0.30574224 |
| 132 | FYN | 0.30174164 |
| 133 | STK4 | 0.27876232 |
| 134 | MAP2K2 | 0.26666885 |
| 135 | SIK3 | 0.25735403 |
| 136 | PDPK1 | 0.24050134 |
| 137 | PRKAA2 | 0.23984342 |
| 138 | PAK2 | 0.23734889 |
| 139 | PKN2 | 0.23592926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.32580068 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.24480517 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.17411740 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.11863486 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.80840847 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.77781498 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.53512476 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.35130619 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.28486811 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28324240 |
| 11 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.06441885 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99539599 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.95157411 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.94170536 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88395903 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87987701 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73646122 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63539780 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60580247 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.60047966 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56734507 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46903144 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.46484481 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45565468 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.44884909 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.44703260 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42672032 |
| 28 | Prion diseases_Homo sapiens_hsa05020 | 1.42585670 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42281564 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38455244 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36450620 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31243242 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.30453623 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29925446 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27950854 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27463872 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15862737 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13232384 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11412839 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08152407 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.08068554 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06430668 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06170904 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03867687 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.00721978 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.99446331 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98318334 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.97371063 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.97351181 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97113766 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93292847 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93243638 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.91540143 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.86676987 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83825451 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.81253045 |
| 57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80359342 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79161345 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79081560 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.78629032 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.75006297 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74506067 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.71268042 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70466331 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70417438 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69766896 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69512129 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62969556 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60920647 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.59274607 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58863401 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.58294946 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58173792 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57982518 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57954824 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.57765248 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57104232 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56202879 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55792531 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54337994 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54052466 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53359589 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52870365 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51994793 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51913198 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.51523597 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51416583 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.51265231 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50400762 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49359763 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49076960 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48285724 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47269125 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46317570 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45575769 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45273949 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43523753 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43252575 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40809897 |
| 100 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39171582 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36783244 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35510993 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34516638 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33739851 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33196205 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32691953 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31001784 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30624917 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30390647 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28809498 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27912700 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27622611 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27499826 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26549752 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.25734172 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24603796 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.24508720 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23044018 |

